Liontrust UK Focus Fund Q2 2025 review

Past performance does not predict future returns. You may get back less than you originally invested. Reference to specific securities is not intended as a recommendation to purchase or sell any investment.

The Liontrust UK Focus Fund returned 8.4% over the quarter, versus the 4.4% return from its comparator benchmark, the FTSE All Share Index, and the 7.4% average return from the Investment Association UK All Companies sector, also a comparator benchmark.*

The UK market rose over the quarter, recovering from an initial sell-off triggered by President Trump’s ‘Liberation Day’ announcement. The initial market turbulence eased after a temporary suspension of most tariffs and the announcement of several new trade deals, with the UK the first country to benefit. Market strength was driven by strong performance in industrials such as BAE systems and Rolls-Royce, reflecting optimism around increased defence spending and tariff relief. In contrast, healthcare stocks struggled due to policy proposals by the Trump administration.

From a sector perspective, an underweight exposure to energy and an overweight in industrials contributed the most positively to relative performance. An underweight exposure to financials and telecommunications had the most significant negative impact on relative performance.

Positive stock attribution

The most significant positive contributor to relative performance was an overweight position in Dunelm, the home furnishings retailer. Dunelm had strong Q3 results where revenue came in ahead of expectations.

An underweight position in AstraZeneca, the global pharmaceuticals company, was the second leading contributor to the Fund’s relative returns. The stock declined following US proposals to implement a ‘Most Favoured Nation’ pricing policy, which would force drugmakers to align US prices with the lowest prices charged internationally.

Negative stock attribution

The most significant detractor from relative performance was an overweight position in Thermo Fisher Scientific, the US life sciences and clinical research company. 2025 guidance was lowered because of US-China tariffs and US policy changes.

Not holding Rolls-Royce, the aerospace company, was the second most significant detractor from relative performance. The shares performed strongly due to tariff relief and continued strength in its aerospace division, driven by defence optimism and strong civil aviation demand.

Trading activity

During the quarter we initiated new positions in Trainline and Marshalls.

Trainline is an online rail ticketing platform. It has a leading market position in the UK online market, and online sales are becoming a bigger proportion of ticket sales. They are expanding into Europe where the liberalization of rail networks is allowing multi-operator competition. Political uncertainty has weighed on the shares and created an attractive entry point into a market-leading platform.

Marshalls is a UK manufacturer of landscaping, building and roofing products. While landscaping volumes are down over 30% from their peak and profits are almost 80% down, we believe there is significant recovery potential within the division. The building products division also offers recovery potential, with volumes down around 25%. Meanwhile, the roofing business continues to perform extremely well and is one of the best performing businesses in the industry. We believe that there is huge earnings recovery potential for the business with volumes close to all-time lows and an attractive valuation.

We trimmed our positions in Verisk and Relx over valuation concerns.

Outlook

There are several crosscurrents facing global businesses at present – a highly volatile geopolitical and tariff environment, an unusually changeable FX market, supply chain reconfigurations away from a dependence on China, and an uncertain consumer environment. At best this presents a challenging environment for businesses to navigate and one in which we imagine the confidence is not there for businesses to invest.

From a UK consumer perspective where we are well exposed in the portfolio (Greggs, Dunelm, Whitbread predominantly) the outlook is mixed – consumer confidence is weak, despite relatively strong real wage growth, and UK unemployment hit a four year high in June. Companies are reporting a mixed picture: UK banks see stable credit conditions and value-focused retailers like Greggs, Primark (AB Foods), and B&M have issued cautious updates. The bond market has woken up to the debt burden in both the UK and the US, and in the UK the Labour party looks to now need to go down the route of future tax rises. The consumer balance sheet seems strong, which should provide support to spending when confidence eventually picks up, but on aggregate consumers remain hesitant to convert this to spending.

Our focus remains on constructing a well-balanced and diversified portfolio of advantaged businesses. Our confidence in the medium-term outlook for the portfolio comes from the excellent strategic, operational, and financial progress that the vast majority of the companies in the portfolio have made (and continue to make) over the last couple of years. Shorter term risks remain high across markets.

Discrete years' performance (%) to previous quarter-end:

	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21
Liontrust UK Focus X Acc GBP	9.6%	15.6%	17.5%	-21.4%	24.8%
FTSE All Share	11.2%	13.0%	7.9%	1.6%	21.5%
IA UK All Companies	8.7%	12.6%	6.2%	-8.5%	27.7%
Quartile	3	1	1	4	2

*Source: Financial Express, as at 30.06.25, primary share class, total return, net of fees and income reinvested.

KEY RISKS

Past performance does not predict future returns. You may get back less than you originally invested.

We recommend this fund is held long term (minimum period of 5 years). We recommend that you hold this fund as part of a diversified portfolio of investments.

Overseas investments may carry a higher currency risk. They are valued by reference to their local currency which may move up or down when compared to the currency of the Fund.
The Fund, may in certain circumstances, invest in derivatives but it is not intended that their use will materially affect volatility. Derivatives are used to protect against currencies, credit and interest rate moves or for investment purposes. The use of derivatives may create leverage or gearing resulting in potentially greater volatility or fluctuations in the net asset value of the Fund. A relatively small movement in the value of a derivative's underlying investment may have a larger impact, positive or negative, on the value of a fund than if the underlying investment was held instead.
Credit Counterparty Risk: outside of normal conditions, the Fund may hold higher levels of cash which may be deposited with several credit counterparties (e.g. international banks). A credit risk arises should one or more of these counterparties be unable to return the deposited cash.
Concentration Risk: the Fund may have a concentrated portfolio, i.e. hold a limited number of investments (35 or fewer) or have significant sector or factor exposures. If one of these investments or sectors / factors fall in value this can have a greater impact on the Fund's value than if it held a larger number of investments across a more diversified portfolio.
Diversification Risk: the Fund is expected to invest in companies predominantly in a single country which maybe subject to greater political, social and economic risks which could result in greater volatility than investments in more broadly diversified funds.
Liquidity Risk: the Fund may encounter liquidity constraints from time to time. The spread between the price you buy and sell shares will reflect the less liquid nature of the underlying holdings.
ESG Risk: there may be limitations to the availability, completeness or accuracy of ESG information from third-party providers, or inconsistencies in the consideration of ESG factors across different third party data providers, given the evolving nature of ESG.

The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

DISCLAIMER

This material is issued by Liontrust Investment Partners LLP (2 Savoy Court, London WC2R 0EZ), authorised and regulated in the UK by the Financial Conduct Authority (FRN 518552) to undertake regulated investment business.

It should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. The investment being promoted is for units in a fund, not directly in the underlying assets.

This information and analysis is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content, no representation or warranty is given, whether express or implied, by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified.

This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID) and/or PRIIP/KID, which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.com or direct from Liontrust. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances.

Understand common financial words and termsSee our glossary